Jump to Navigation

HOVON 146

Titel: Blinatumomab added to prephase and consolidation therapy in precursor B-acute lymphoblastic leukemia in adults. A phase II trial

Studie gesloten per 30 november 2020

Studiemedicatie:

BEACONprotocol:  

Principal Investigator AMC: Bart Biemond
Studie coordinator: Roberto Liu

Aanmelden patienten via trialbureau hematologie (sein 29255, hemat.trial@amc.nl)